Last updated on June 13th, 2024
CbdMD, a cannabidiol (CBD) brand, has retained former US Food and Drug Administration (FDA) official Dr. Sibyl Swift as a regulatory consultant to oversee the company’s regulatory initiatives and prepare its products for further certifications. 
From 2014 to 2020, Swift served in various capacities at the FDA, most notably as the associate director for research and strategy in the FDA’s Office of Dietary Supplement Programs, where she worked closely on the agency’s science, research, compliance, enforcement and policy initiatives. In 2020, she served as the SVP for scientific and regulatory affairs for the Natural Products Association (NPA), where she addressed regulatory policies related to NDI notifications, FDA guidance and claims substantiation.
“We are grateful to Dr. Daniel Fabricant and the NPA for allowing Dr. Swift to join our team. Dr. Swift’s experience and science-based approach demonstrates to our customers, the FDA and global regulatory authorities that cbdMD is committed to having our products meet the highest regulatory standards for quality and safety,” said Chairman and Co-CEO Marty Sumichrast.
CbdMD Inc. is one of the most trusted and most recognized cannabidiol (CBD) brands, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical skincare products, CBD bath bombs and CBD pet products. CbdMD is a member of the NPA, a partner of Bellator MMA and Life Time Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.”
CbdMD is headquartered in Charlotte, North Carolina.
